AT
Aprea Therapeutics Inc
🇺🇸XNAS.APREUnited StatesHealthcare
$0.73USDdown -0.02 (-2.67%)ClosedDelayed1:51 AM
Price$0.73-0.02 (-2.67%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03836J2015
- CUSIP
- 03836J102
Company
- Employees
- 8
- Headquarters
- Doylestown, United States
- Website
- https://aprea.com
- CEO
- Dr. Oren Gilad Ph.D.
Market
- Shares outstanding
- 12.6M
- Market cap
- $9.19M
Highlights
- Market cap
- $9.19M
- EPS LTM
- -$0.23
- P/E LTM
- -3.48
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $5.19K-99.38%down year on year
- Net income
- -$12.31M+11.14%up year on year
- Gross margin
- 84,345.63%+8,197.91%up year on year
- Free cash flow
- -$12.18M+4.38%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.